Huang et al. [72] demonstrated that ADPGK-AS1 could promote gastric cancer progression via sponging miR-3196 and, therefore, upregulating the KDM1B gene, providing a novel prognostic biomarker and therapeutic target for GC patients. This evidence concerns the gene ADPGK and gastric cancer.